Monday, January 14, 2019

Cirius Therapeutics Files For IPO

San Diego-based Cirius Therapeutics, a venture-backed biotech startup developing treatments for liver disease, has filed for an IPO, saying it is looking to raise up to $86.25M in funding on the Nasdaq Global Select Market as CSTX. The company's IPO is being underwritten by Citigroup, Credit Suisse, Needham & Company, and Wedbush PacGrow. The startup--led

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.